Pampena R, et al. - Researchers intended to ascertain whether the response to ingenol mebutate (IngMeb) therapy could be predicted by certain dermoscopic features of actinic keratosis (AK) of the face and scalp areas. Findings revealed that AKs dermoscopically characterized by red pseudonetwork and located on the face exhibited an independent correlation with a complete dermoscopic response to 0.015% IngMeb therapy; whereas microerosions served as negative predictors. They concluded that the response to 0.015% IngMeb therapy, along with the location on the face could be speculated by specific dermoscopic features of AK.